Connect Biopharma (CNTB)
0.84
-0.04 (4.55%)
Upcoming Events
Latest Headlines
Leerink Assumes Connect Biopharma Holdings Ltd (CNTB) at Outperform
October 12, 2026 7:19 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Connect Biopharma Holdings Ltd (CNTB)
October 8, 2026 7:08 AM - StreetInsider
Form SCHEDULE 13G Connect Biopharma Holdin Filed by: BML Investment Partners, L.P.
October 6, 2026 7:53 PM - SEC Filing
Form 4 Connect Biopharma Holdin For: Sep 30 Filed by: Xanthopoulos Kleanthis Gabriel
October 1, 2026 5:19 PM - SEC Filing
Form 4 Connect Biopharma Holdin For: Sep 30 Filed by: LIU JEAN I
October 1, 2026 5:17 PM - SEC Filing
Connect Biopharma Holdings Ltd (CNTB) PT Lowered to $5 at BTIG
September 30, 2026 12:38 PM - StreetInsider
Connect Biopharma stock jumps on positive COPD trial data
September 30, 2026 10:46 AM - StreetInsider
3 Biotech Stocks Throwing Their Weight Around, and Another that Wants to Help You Lose Yours
September 30, 2026 10:23 AM - StreetInsider
Form 8-K Connect Biopharma Holdin For: Sep 30
September 30, 2026 7:05 AM - SEC Filing
Connect Biopharma reports positive Phase 2 data for COPD drug rademikibart
September 30, 2026 7:00 AM - StreetInsider
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation
September 30, 2026 7:00 AM - StreetInsider
Connect Biopharma Holdings Ltd (CNTB) PT Lowered to $5 at Oppenheimer
September 22, 2026 8:00 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Connect Biopharma Holdings Ltd (CNTB)
September 17, 2026 6:54 AM - StreetInsider
Connect Biopharma Holdings Ltd (CNTB) PT Lowered to $6 at Canaccord
September 16, 2026 6:50 AM - StreetInsider
Form 8-K Connect Biopharma Holdin For: Sep 15
September 15, 2026 7:07 AM - SEC Filing
Connect Biopharma reports Phase 2 asthma drug data with mixed results
September 15, 2026 7:00 AM - StreetInsider
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adult and Adolescent Participants with Ast
September 15, 2026 7:00 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Connect Biopharma Holdings Ltd (CNTB)
September 14, 2026 7:39 AM - StreetInsider
Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026 4:05 PM - StreetInsider
Canaccord Reiterates Buy Rating on Connect Biopharma Holdings Ltd (CNTB)
August 26, 2026 6:33 AM - StreetInsider
Form SCHEDULE 13G/A Connect Biopharma Holdin Filed by: Ikarian Capital, LLC
August 14, 2026 9:25 PM - SEC Filing
Form SCHEDULE 13G/A Connect Biopharma Holdin Filed by: Wei Zheng
August 14, 2026 10:45 AM - SEC Filing
Connect Biopharma (CNTB) Tops Q2 EPS by 189c
August 13, 2026 4:18 PM - StreetInsider
Form 10-Q Connect Biopharma Holdin For: Jun 30
August 12, 2026 4:17 PM - SEC Filing
Form 8-K Connect Biopharma Holdin For: Aug 12
August 12, 2026 4:14 PM - SEC Filing
Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026 4:05 PM - StreetInsider
Full Article List
